← Back
$TSHA All transactions

Taysha Gene Therapies, Inc.

A

$ Value

$0

Shares

648,000

Price

$0

Filed

Jan 14

Insider

Name

Nolan Sean P.

Title

Chief Executive Officer

CIK

0001569926

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

648,000

Footnotes

Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date. | The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC. | 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Filing Info

Accession No.

0001569926-26-000002

Form Type

4

Issuer CIK

0001806310

Nolan Sean P.'s History

Date Ticker Type Value
2026-01-26 TSHA $190K
2026-01-23 TSHA $650K
2026-01-12 TSHA A $0
2026-01-12 TSHA A $0
2025-05-13 VTR A $185K

Other Insiders at TSHA (90d)

Insider Bought Sold Last
Nolan Sean P.
Chief Executive Officer
$840K 2026-01-26
Nagendran Sukumar
President and Head of R&D
$1.4M 2026-04-10
Alam Kamran
CHIEF FINANCIAL OFFICER
$493K 2026-02-04